Daiwa Securities Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49K | Buy |
15,844
+15,449
| +3,911% | +$47.8K | ﹤0.01% | 1069 |
|
|
2025
Q1 | $1K | Hold |
395
| – | – | ﹤0.01% | 1207 |
|
|
2024
Q4 | $1K | Hold |
395
| – | – | ﹤0.01% | 1241 |
|
|
2024
Q3 | $2K | Hold |
395
| – | – | ﹤0.01% | 1211 |
|
|
2024
Q2 | $1K | Hold |
395
| – | – | ﹤0.01% | 1267 |
|
|
2024
Q1 | $1K | Hold |
395
| – | – | ﹤0.01% | 1279 |
|
|
2023
Q4 | $1K | Hold |
395
| – | – | ﹤0.01% | 1277 |
|
|
2023
Q3 | $1K | Hold |
395
| – | – | ﹤0.01% | 1226 |
|
|
2023
Q2 | $1K | Hold |
395
| – | – | ﹤0.01% | 1247 |
|
|
2023
Q1 | $1K | Hold |
395
| – | – | ﹤0.01% | 1226 |
|
|
2022
Q4 | $1K | Hold |
395
| – | – | ﹤0.01% | 1244 |
|
|
2022
Q3 | $1K | Hold |
395
| – | – | ﹤0.01% | 1254 |
|
|
2022
Q2 | $1K | Hold |
395
| – | – | ﹤0.01% | 1257 |
|
|
2022
Q1 | $1K | Hold |
395
| – | – | ﹤0.01% | 1278 |
|
|
2021
Q4 | $2K | Buy |
395
+235
| +147% | +$1.19K | ﹤0.01% | 1260 |
|
|
2021
Q3 | $1K | Hold |
160
| – | – | ﹤0.01% | 1251 |
|
|
2021
Q2 | $0 | Hold |
160
| – | – | ﹤0.01% | 1248 |
|
|
2021
Q1 | $1K | Hold |
160
| – | – | ﹤0.01% | 1175 |
|
|
2020
Q4 | $1K | Buy |
+160
| New | +$1K | ﹤0.01% | 1152 |
|
|
2019
Q4 | – | Sell |
-304
| Closed | – | – | 1183 |
|
|
2019
Q3 | $0 | Hold |
304
| – | – | ﹤0.01% | 1162 |
|
|
2019
Q2 | $1K | Hold |
304
| – | – | ﹤0.01% | 1150 |
|
|
2019
Q1 | $1K | Hold |
304
| – | – | ﹤0.01% | 1139 |
|
|
2018
Q4 | $1K | Hold |
304
| – | – | ﹤0.01% | 1106 |
|
|
2018
Q3 | $3K | Hold |
304
| – | – | ﹤0.01% | 1084 |
|
|
2018
Q2 | $2K | Hold |
304
| – | – | ﹤0.01% | 1120 |
|
|
2018
Q1 | $2K | Buy |
+304
| New | +$2K | ﹤0.01% | 1105 |
|